Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

23andMe Opens Up FDA Pathway For DTC Genetic Predisposition Tests

Apr 06 2017

• By Ferdous Al-Faruque

Related Content

23andMe Has Accelerated The Consumer Genomics Debate

Feb 24 2014

FDA, 23andMe Open Up Market Pathway For DTC Genetics

Feb 20 2015

FDA Comes Down Hard On 23andMe, Putting Consumer-Directed Genetic Testing On Notice

Nov 25 2013

Related Companies

23andMe, Inc.

Additional Topics

United States Regulation In Vitro Diagnostics Medical Device

More from In Vitro Diagnostics

More from Diagnostics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window